Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003

Sierra JM;Sánchez F;Castro P;Salvadó M;de la Red G;Libois A;Almela M;March F;Español M;Sambeat MA;Romeu J;Brugal MT;de Olalla PG;Gatell JM;Vila J;García F;Colomés JLL;Caylà JA;Coll P;;
Medicine 2006 Vol. 85 pp. -
263
jm2006medicinegroup

Abstract

An unexplained resurgence of Group A streptococci (GAS) infections has been observed since the mid-1980s in the United States and Europe, particularly among intravenous drug users (IDUs). Several risk factors have been identified. Mutations in the capsule synthesis regulator genes (csrRS) have been …

Keywords

National Center for Biotechnology Information NCBI NLM MEDLINE gel humans pubmed abstract nih national institutes of health national library of medicine adult female male adolescent middle aged Prospective Studies risk factors Retrospective Studies DNA Sequence Analysis anti-bacterial agents / therapeutic use mutation disease outbreaks population surveillance substance abuse intravenous / complications cross infection / microbiology electrophoresis cross infection / epidemiology* soft tissue infections / microbiology pulsed-field streptococcal infections / microbiology soft tissue infections / drug therapy soft tissue infections / epidemiology* cross infection / drug therapy streptococcus pyogenes / isolation & purification* streptococcal infections / epidemiology* spain / epidemiology streptococcal infections / drug therapy intravenous / epidemiology* cluster analysis beta-lactams / therapeutic use molecular epidemiology streptococcus pyogenes / genetics restriction mapping pmid:16721256 doi:10.1097/01.md.0000224707.24392.52 josep m sierra francesca sánchez pere coll streptococcus pyogenes / drug effects intravenous / microbiology

Access

URL:
http://www.ncbi.nlm.nih.gov/pubmed/16721256

Citation

ID: 273645
Ref Key: jm2006medicinegroup
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
273645
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store